Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
2021The use of L-arginine in the treatment of non-alcoholic steatohepatitis with metabolic syndromeMandryk, O.; Shuiskyi, A.; Metelskyi, V.
2021Inhibition of steatosis and liver fibrosis progression in patients with nonalcoholic steatohepatitis and stage two essential hypertension due to the treatment with hepadif, ezetimibe and fosinoprilMandryk, O.; Yeleniuk, I.; Stasiuk, V.
2021Specific features of blood lipid profile in patients with chronic obstructive pulmonary disease and non-alcoholic steatogepathitis depending on comorbid hypertension and obesityMandryk, O.; Kryzhevska, A.; Rusnak, Z.
2021The influence of changes in the blood lipid spectrum on the development and progression of diabetic gastropathy depending on the type of concerting sugarMandryk, O.; Humenna, I.; Nebyla, O.
2021Features of 24 hour arterial pressure monitoring in patients with comorbid nonalcoholic steatohepatitis depending on the body weight indexMandryk, O.; Stasiuk, V.; Yeleniuk, I.
2021The indicators of the liver’s dynamic state in patients with non-alcoholic steatohepatitis, depending on the presence of comorbid bronchial asthma and obesityMandryk, O.; Rykhlo, I.
2021Tactics of choice of antihypertensive therapy for patients with arterial hypertension with concomitant chronic obstructive diseaseMandryk, O.; Hrynyk, A.; Halak, Yu.
2021Indicators of daily blood pressure monitoring in patients with non-alcoholic steatohepatitis with comorbid obesityMandryk, O.; Pidgaina, V. A.
2021Modern approaches to the management of patients with non-alcoholic steatogepatitis against obesityMandryk, O.; Kifa, A.; Vakaruk, D.